Mobile Cardiac Telemetry Market By Component (Devices {Patch-based Monitors, Wearable MCT Devices, Handheld MCT Devices}, Software {Cloud-Based Platforms, On-Premise Platforms, AI and Predictive Analytics Software}, Services {Monitoring Services, Data Management & Analysis Services, Technical Support & Maintenance}), By Application (Atrial Fibrillation, Bradycardia, Tachycardia, Ventricular Fibrillation, Others), By End-user (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Home Healthcare, Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

---

What trends will shape Mobile Cardiac Telemetry Market in the coming years?

The Mobile Cardiac Telemetry Market accounted for USD 1.12 Billion in 2024 and USD 1.26 Billion in 2025 is expected to reach USD 4.01 Billion by 2035, growing at a CAGR of around 12.3% between 2025 and 2035. Mobile Cardiac Telemetry Market is defined as the segment that deals with the production, delivery, and utilization of real-time heart monitoring technology, which patients can wear during their daily routine. These portable medical devices are used to measure cardiac rhythms and regularly report them to healthcare specialists using wireless communication networks. This will enable the early diagnosis of abnormal heart rates, including arrhythmias, which may not be noted even when an ECG test is performed on a short-term basis or even in-clinic.

They particularly find use with patients who have fainting spells that have no clear cause, with palpitations, or those who are suspected to be suffering from atrial fibrillation. It is due to the technology being able to give a diagnosis faster, allowing treatment earlier, that the risk of heart attacks or strokes can be raised substantially. MCT has an extended monitoring time, unlike the conventional Holter monitors, which may go on up to 30 days and give real-time alerts, which could even call for immediate medical attention in case of emergencies. 

What do industry experts say about the Mobile Cardiac Telemetry Market trends?

“These findings challenge the long-held assumption that frequent symptoms justify short-duration monitoring. Nearly two-thirds of daily-symptom patients with actionable arrhythmias were undetected in the first 48 hours, underscoring the need for extended continuous monitoring.”

• Dr. Mintu P. Turakhia, Chief Medical & Scientific Officer, iRhythm Technologies

Which segments and geographies does the report analyze?

What are the key drivers and challenges shaping the Mobile Cardiac Telemetry Market?

Is the rising global incidence of atrial fibrillation and cardiac arrhythmias increasing demand for long-term heart monitoring solutions?

The rising trend in the Global Burden of Atrial fibrillation (AFib) and other cardiac arrhythmias is one of the major factors contributing to the Mobile Cardiac Telemetry Market, as it blatantly indicates the importance of extended heart monitoring (prolonged and real-time). Specifically, AFib is a highly common and frequently asymptomatic disorder that affects about 33 million people globally in 2020, and its prevalence sharply increases in older age groups, so its early detection is almost impossible without constant telemetry. The reason is that projections of the number of people with AFib in the U.S. estimate 12.1 million by 2030, which underscores the expansion of the patient base that needs to be monitored.

The intermittent occurrence of AFib episodes makes most of them undetected with the use of a standard short-term ECG, which prompts healthcare providers to use MCT devices as the only method to produce precise, around-the-clock monitoring. Moreover, the world prevalence of AF/AFL has increased by more than twofold since the year 1990 and has reached 52.6 million prevalent cases in 2021, with nearly 4.5 million registered occurrences in the same year. This compelling data provided by the major institutions proves the immediate need for long-term monitoring, making MCT solutions a critical instrument in early diagnosis or risk assessment to achieve a better cardiac outcome.

Are healthcare systems shifting toward remote and home-based patient monitoring to reduce hospital burden?

The move towards remote patient monitoring and home-based monitoring and follow-up of patients by the healthcare system is on the increase, and this has been a major booster in the Mobile Cardiac Telemetry Market. Remote monitoring facilitates the use of virtual wards and hospital-at-home models, which provide uninterrupted care to patients without necessarily involving the use of a hospital bed, especially to those with cardiac ailments. The analysis of American studies conducted by the CDC revealed that a prompt outpatient treatment of a heart failure patient provided a decrease in 30-day readmission rates of 21% thus proving the efficiency of telehealth initiatives used in the improvement of remote monitoring strategies.

These programs rely on MCT devices that monitor cardiac data in real-time and help clinicians identify arrhythmias at an early stage and take early intervention, which is a powerful feature. The reduced readmission rates are reflected in improved patient outcomes, such as fewer complications and mortality, and massive cost reduction to the healthcare systems. Health organizations and governments are joining in the investment in telemetry infrastructure to accommodate these models, as they are seen as an important method of reducing strain on hospitals.

Are the high initial costs of MCT devices and services restricting adoption in low-income regions?

High initial expenses in terms of devices and services used in the Mobile Cardiac Telemetry Market are a primary element that inhibits them, particularly in low-income and developing locations. These systems normally feature some advanced wearable monitors, the capability of wireless transmission, some platform software of artificial intelligence, as well as continuous monitoring services, and this leads to high costs of upfront expenditures on the operations. To most healthcare institutions in developing regions, this kind of technology is unaffordable.

Moreover, there is also the problem of the absence of complete insurance coverage and very low government reimbursement programs, which also add to the issue of affording MCT services to the patients. Long-term cardiac monitoring is extremely expensive in most cases in places where healthcare is based on out-of-pocket payment, and the prevalence of arrhythmia is high. Other infrastructure issues that also increase the costs of implementation include low internet reliability, a lack of adequate data systems, and a shortage of skilled personnel.

Can the integration of MCT with mobile health apps and cloud-based platforms enhance patient engagement and provider efficiency?

The applicability of mobile cardiac telemetry (MCT), mobile health apps, and the cloud system is a potential prospect in the mobile cardiac telemetry (MCT) market to improve patient involvement and provider productivity. Patients are able to monitor and see their cardiac-related information in real-time as it is received through mobile apps, and this increases awareness of the general patients and also improves compliance and early reporting of symptoms. By so doing, such empowerment will either translate to patient satisfaction or more patient outcomes.

On the provider side, cloud computing gives the business an opportunity to transmit data without problems, directly access it, and analyze results automatically, subsequently giving clinicians the opportunity to make decisions in time and on an informed path. These systems are compatible with alerts related to abnormal rhythms, AI-aided diagnostics, and electronic health records integration with workflow optimization and less hospital reliance. It also allows the care teams to work remotely and observe different patients at the same time.

Is there scope for growth in emerging markets like Southeast Asia and Latin America due to increasing healthcare digitization?

Emerging markets like Southeast Asia and Latin America are potential markets with huge growth opportunities in the Mobile Cardiac Telemetry Market due to fast-paced healthcare digitalization and investments in telehealth facilities. With governments in such areas focused on the digital health change, the potential to install MCT devices is soaring vigorously. The use of remote monitoring devices in countries such as Brazil, Mexico, India, Indonesia, and the Philippines is on the rise as these countries attempt to deal with the burden of cardiovascular diseases.

Such areas are currently witnessing an upsurge of smartphone users, internet accessibility, and the use of mobile health applications, complicating MCT implementations in these locations. Moreover, the rising awareness of heart health and the rising home and middle-income population are also adding to the demand for easy-to-afford and easy-to-use cardiac monitoring technologies. There are also opportunities in the deployment of MCT in the under-resourced settings since international collaborations and donor-led healthcare initiatives are occurring, coupled with public-private partnerships.

What are the key market segments in the Mobile Cardiac Telemetry industry?

Based on the Component, the Market of Mobile Cardiac Telemetry has been classified into Devices, Software, and Services. Devices are the most dominant unit in the Mobile Cardiac Telemetry Market. It is mostly so because wearable and patch monitors have become quite widespread due to their ability to monitor the heart rhythm in real time with a high degree of accuracy. Telemetry systems are based on devices and have the features of remote and ambulatory monitoring, which represents the key to the timely diagnosis of arrhythmias and cardiac irregularities.

They have boosted the popularity of these MCT devices due to the increase in cardiovascular diseases and the need to have patient-friendly and non-invasive gadgets. The wearable ones are especially liked due to their compact size, ease of wearing, wires extension capability to the care providers. The longer tracking times and high level of patient adherence to patch-based monitors compared to the traditional Holters have also resulted in increased popularity of the former in recent years. As the sensor technology and wireless connectivity develop, the devices segment remains the front-runner in the MCT market in terms of usage as well as innovations.

Based on the Application, the Market of Mobile Cardiac Telemetry has been classified into Atrial Fibrillation, Bradycardia, Tachycardia, Ventricular Fibrillation, and Others. Atrial Fibrillation application forms the leading product segment in the Mobile Cardiac Telemetry Market. The most widely occurring cardiac arrhythmia is atrial fibrillation (AFib), especially among the aging population. It is not easily detectable by the traditional short-term ECG techniques, and this is the reason MCT devices have a very high preference in carrying out continuous and long-term monitoring.

MCT allows making an early diagnosis and intervening in time, which minimizes the threat of complications in the form of stroke and heart failure with AFib. This has come in the wake of increased global burden of atrial fibrillation resulting from aging populations and lifestyle choices such as obesity and high blood pressure, which has also led to a huge demand for real-time monitoring solutions. There is also a preference for MCT as a method of managing AFib because it captures data regarding asymptomatic episodes and produces accurate, actionable information. These are the reasons why atrial fibrillation is the most common application in adopting the MCT technologies.

Which regions are leading the Mobile Cardiac Telemetry Market, and why?

North America Mobile Cardiac Telemetry Market is leading due to the presence of developed healthcare infrastructure, high use of remote monitoring management technologies, and favorable reimbursement systems. The United States provides most of the largest share in the region, mainly due to the increasing burden of heart arrhythmias and increasing awareness of early-detection practice among patients and medical practitioners.

The availability of major market participants and continuous product advancement and FDA approval of the next generation wearable telemetry devices also aid in the development of this region. Moreover, real-time clinical decision-making is possible because of the extensive use of the concept of the digital health record and the connection of MCT data to the systems of hospitals. The promotional activities that healthcare organizations and insurance companies are carrying out to promote the concept of value-based care are also accelerating the adoption of remote cardiac monitoring solutions.

The Asia Pacific Mobile Cardiac Telemetry Market is one of the rapidly emerging markets, driven by the growing incidence of cardiovascular diseases and increased healthcare awareness. Other nations, such as China, India, Japan, and South Korea, are facing a surge in the demand for remote cardiac monitoring due to urbanization, population aging, and lifestyle-related health concerns. The increasing penetration of smartphone technology and the internet promotes the use of wearable heart devices in the region as well.

Asian Pacific Healthcare systems are slowly being embedded with digital health tools, and governments are investing in infrastructure related to telemedicine to make the system rural-friendly. Although the market is still in its formative years, domestic suppliers and startups are venturing into the market, having grasped cost-effective MCT applications based on local requirements. Also, international manufacturers of the devices are partnering with the regional healthcare providers, which are increasing product reach and supply.  

What does the competitive landscape of the Mobile Cardiac Telemetry Market look like?

The Mobile Cardiac Telemetry Devices Market industry segment is competitive, with a combination of large, traditional medical equipment suppliers, as well as young, emerging health technology firms. The market is dominated by big players like BioTelemetry, Medtronic, and iRhythm Technologies, who have well-diversified portfolios of FDA-approved products, as well as extensive geographical coverage. Such businesses spend a lot on research and development to improve in-time data analytics, patient ease, and concurrence with digital wellness systems.

Smaller organizations such as Biotricity and InfoBionic are becoming popular because they provide small, easily affordable, and easy-to-utilize MCTs with AI-based diagnostic resources. Previous strategic mergers and acquisitions, which include the internalization of Preventice Solutions into Boston Scientific, are slowly solidifying the market and enlarging the level of technology that is in the hands of bigger companies. It is also becoming a pattern of collaboration between device manufacturers and telehealth platforms to aid with remote cardiac care models.

Mobile Cardiac Telemetry Market, Company Shares Analysis, 2024

To explore in-depth analysis in this report - Request Sample Report

Which recent mergers, acquisitions, or product launches are shaping the Mobile Cardiac Telemetry industry?

• In March 2025, iRhythm shared findings at ACC.25, revealing that among 1.1 million patients, short‑term Holter monitoring missed 64 % of actionable arrhythmias within the first 48 hours, underscoring the diagnostic superiority of its Zio long‑term continuous monitoring (LTCM) devices.

Report Coverage:

By Component

• Devices
  • Patch-based Monitors
  • Wearable MCT Devices
  • Handheld MCT Devices
• Software
  • Cloud-Based Platforms
  • On-Premise Platforms
  • AI and Predictive Analytics Software
• Services
  • Monitoring Services
  • Data Management & Analysis Services
• Technical Support & Maintenance

By Application

• Atrial Fibrillation
• Bradycardia
• Tachycardia
• Ventricular Fibrillation
• Others

By End-user

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Home Healthcare
• Others

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of the Middle East & Africa

List of Companies:

• BioTelemetry, Inc.
• iRhythm Technologies, Inc.
• Biotricity Inc.
• Preventive Solutions, Inc.
• ZOLL Medical Corporation
• Medtronic plc
• GE HealthCare Technologies Inc.
• Bardy Diagnostics, Inc.
• VivaQuant LLC
• ScottCare Corporation
• Applied Cardiac Systems, Inc.
• InfoBionic, Inc.
• LifeWatch AG
• Telerhythmics, LLC
• Qardio, Inc.

Frequently Asked Questions (FAQs)